HK1029919A1 - Method for preventing the misuse of a transdermal therapeutic system - Google Patents

Method for preventing the misuse of a transdermal therapeutic system

Info

Publication number
HK1029919A1
HK1029919A1 HK01100389A HK01100389A HK1029919A1 HK 1029919 A1 HK1029919 A1 HK 1029919A1 HK 01100389 A HK01100389 A HK 01100389A HK 01100389 A HK01100389 A HK 01100389A HK 1029919 A1 HK1029919 A1 HK 1029919A1
Authority
HK
Hong Kong
Prior art keywords
misuse
therapeutic system
transdermal therapeutic
preventing
unauthorised
Prior art date
Application number
HK01100389A
Inventor
Frank Becher
Ann-Katrin Klink
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of HK1029919A1 publication Critical patent/HK1029919A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

According to the invention, denaturing agents are added to a transdermal therapeutic system to prevent misuse in the form of unauthorised oral application.
HK01100389A 1997-10-01 2001-01-15 Method for preventing the misuse of a transdermal therapeutic system HK1029919A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (en) 1997-10-01 1997-10-01 Transdermal patches containing substance with unpleasant taste
PCT/EP1998/005955 WO1999016428A1 (en) 1997-10-01 1998-09-18 Method for preventing the misuse of a transdermal therapeutic system

Publications (1)

Publication Number Publication Date
HK1029919A1 true HK1029919A1 (en) 2001-04-20

Family

ID=7844345

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100389A HK1029919A1 (en) 1997-10-01 2001-01-15 Method for preventing the misuse of a transdermal therapeutic system

Country Status (23)

Country Link
EP (1) EP1019032B1 (en)
JP (2) JP4755338B2 (en)
KR (1) KR100552102B1 (en)
AT (1) ATE228356T1 (en)
AU (1) AU759609B2 (en)
CA (1) CA2305432C (en)
DE (2) DE19743484C1 (en)
DK (1) DK1019032T3 (en)
ES (1) ES2188021T3 (en)
HK (1) HK1029919A1 (en)
HU (1) HU226644B1 (en)
ID (1) ID24333A (en)
IL (1) IL134479A (en)
MY (1) MY116425A (en)
NO (2) NO319163B1 (en)
NZ (1) NZ503643A (en)
PL (1) PL193066B1 (en)
PT (1) PT1019032E (en)
SK (1) SK3332000A3 (en)
TR (1) TR200000461T2 (en)
TW (1) TW431894B (en)
WO (1) WO1999016428A1 (en)
ZA (1) ZA988904B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (en) * 2004-04-21 2005-11-17 Grünenthal GmbH Anti-abuse drug-containing patch
JP7329857B2 (en) 2018-10-17 2023-08-21 日榮新化株式会社 Adhesive sheet and its manufacturing method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (en) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermal therapeutic system and a method for producing a transdermal therapeutic system for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of poisoning by highly toxic organophosphorus neurotoxins, in particular Soman and its use
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste

Also Published As

Publication number Publication date
AU759609B2 (en) 2003-04-17
CA2305432A1 (en) 1999-04-08
PL339736A1 (en) 2001-01-02
TR200000461T2 (en) 2000-09-21
KR20010030886A (en) 2001-04-16
DE19743484C1 (en) 1999-01-28
JP4755338B2 (en) 2011-08-24
CA2305432C (en) 2007-04-03
NO20001691L (en) 2000-03-31
DK1019032T3 (en) 2003-03-10
IL134479A0 (en) 2001-04-30
JP2009035561A (en) 2009-02-19
PL193066B1 (en) 2007-01-31
MY116425A (en) 2004-01-31
NZ503643A (en) 2003-05-30
NO20001492L (en) 2000-03-22
KR100552102B1 (en) 2006-02-13
SK3332000A3 (en) 2000-11-07
AU9626598A (en) 1999-04-23
TW431894B (en) 2001-05-01
NO20001492D0 (en) 2000-03-22
ZA988904B (en) 1999-04-12
HU226644B1 (en) 2009-05-28
EP1019032A1 (en) 2000-07-19
ATE228356T1 (en) 2002-12-15
HUP0003476A3 (en) 2001-04-28
EP1019032B1 (en) 2002-11-27
DE59806468D1 (en) 2003-01-09
WO1999016428A1 (en) 1999-04-08
HUP0003476A2 (en) 2001-02-28
NO20001691D0 (en) 2000-03-31
ES2188021T3 (en) 2003-06-16
PT1019032E (en) 2003-04-30
NO319163B1 (en) 2005-06-27
JP2001517695A (en) 2001-10-09
ID24333A (en) 2000-07-13
IL134479A (en) 2005-07-25

Similar Documents

Publication Publication Date Title
MX9700082A (en) Composition comprising morphine, polypyrrolidone and a polyalkyleneoxide.
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
IL149890A0 (en) Tnt-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated
BG101131A (en) 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons
AU7077098A (en) Transdermal delivery system
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
ZA962536B (en) Pharmaceutical composition for transdermal administration.
EP1028715A4 (en) Dosage composition for nasal delivery and method of use of the same
WO1999004752A3 (en) Methods for treating skin pigmentation
ZA99104B (en) Method for administering ASPB28-human insulin.
GB2352395A (en) Paroxetine methanesulfonate
IL114294A0 (en) Sterol derivatives
AU8736798A (en) Use of cholinesterase inhibitors for treating attention deficit disorders
AU4428597A (en) Iontophoretic drug delivery system, including method for activating same
AU8239298A (en) Nucleotide-comprising composition
EP0683668A4 (en) Compositions and methods for transdermal drug delivery.
NZ308516A (en) Transdermal therapeutic system (tts) for administering testosterone
HK1029919A1 (en) Method for preventing the misuse of a transdermal therapeutic system
HK1025558A1 (en) Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock
AU5093199A (en) Transdermal delivery system
EP1009421A4 (en) Methods and compositions for enhanced wound healing
AU5434899A (en) Cancer treatment
IL147500A0 (en) Method for delivery of therapeutic agents using a solution of dextrin
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
UA36385A (en) Method for treating generalized periodontitis

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120918